Medical News

RSS

ARIAD reports $159.3 million second-quarter net income

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

5 Aug 2010

Bionovo reports total revenue of $14,000 for second-quarter 2010

Bionovo, Inc. today announced second quarter highlights and financial results for the three months ended June 30, 2010.

5 Aug 2010

Genzyme, Isis announce results of two mipomersen phase 3 studies

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced results of two phase 3 studies of mipomersen in patients who had high cholesterol levels while on maximally tolerated lipid-lowering therapy. In the study of patients with severe hypercholesterolemia, mipomersen reduced LDL-C, the primary endpoint, by 36 percent compared with a 13 percent increase for placebo.

5 Aug 2010

Healthcare professionals to share therapeutic hypothermia knowledge at 'Cool It' program

Healthcare professionals are invited to 'Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patients' September 9 and 10 in Minneapolis. The conference is devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other national experts.“We are sharing what we've learned with physicians and hospitals who are just beginning therapeutic hypothermia programs and with those who want to expand existing programs.”

5 Aug 2010

Abiomed first-quarter fiscal 2011 revenue increases 11% to $22.0 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2011 revenue of $22.0 million, up 11% compared to the same period of fiscal 2010.

5 Aug 2010

Elusys awarded second contract to develop Anthim for treatment of anthrax infection

Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.

5 Aug 2010

Penn. effort fades to override cuts to family planning; Ill. faces budget cuts to health care; Mich. focuses on high cost of chronic disease

The Philadelphia Inquirer: "As two Democratic state lawmakers initiated a campaign to override the governor's veto of $7.5 million for family-planning health centers, six Republican state senators who previously voted to restore the funding reversed course, most likely ending any hopes of restoring the money. Democrats would need at least four Republican votes for an override in the Senate, which now appears unlikely.

5 Aug 2010

Teleflex announces pricing of $350 million 3.875% convertible senior subordinated notes due 2017

Teleflex Incorporated today announced that it priced its previously announced public offering of $350 million in aggregate principal amount of 3.875% convertible senior subordinated notes due 2017. In addition, Teleflex granted the underwriters an option to purchase up to an additional $50 million in aggregate principal amount of convertible notes within 13 days from the date of closing of the offering.

5 Aug 2010

Scientists analyze new technique to quickly identify particular asthma subtypes

For many people afflicted by asthma, treatment can be a frustrating and time-consuming experience. After their initial diagnosis, asthmatics find themselves caught in a trial and error process that can last for months, as doctors gradually escalate their medications to treat their condition effectively with minimal side effects. And until the right medicine and dosage are found, patients continue to suffer attacks that strike without warning and can leave them struggling for breath for hours or even days.

5 Aug 2010

TapImmune inks smallpox vaccine Research and Technology License Option Agreement with Mayo Clinic

TapImmune Inc. announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the development of a smallpox vaccine technology. Research will be conducted by Gregory Poland M.D., at Mayo Clinic, to evaluate novel peptide antigens together with TapImmune's proprietary TAP technology. TapImmune also has an exclusive Option to the smallpox vaccine technology after research studies have been completed under the terms of the agreement.

5 Aug 2010

Senate Democrats hang hopes for state Medicaid money on Maine Republican votes

On Wednesday morning, the Senate took up a state aid package, which includes Medicaid assistance. What follows are summaries of the news coverage in advance of a vote scheduled to begin at 10:40 a.m.

5 Aug 2010

West Michigan Business Review names DCC as 2010 Michigan Innovator

Dynamic Computer Corporation was named a 2010 Michigan Innovator by the West Michigan Business Review on July 28th for their Hand-Hygiene Compliant solution using Radio Frequency Identification. This HHC solution was developed in an effort to reduce the number of healthcare-associated infections that the US healthcare industry is pained with annually.

5 Aug 2010

Certain proteins, genes play key role in regenerating lost body parts: Research

Another option may be on the horizon for patients who lose limbs due to war, accident, or disease. Instead of using artificial legs or arms, patients actually may regrow their own missing limbs. An article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, focuses on research efforts to turn the long-standing dream of human limb regeneration into reality.

5 Aug 2010

Amputation can be prevented when patients are treated by podiatric physicians: Study

Amputation, one of the most devastating and costly consequences of diabetes, can be prevented when patients are treated by podiatric physicians. That's the finding of a national, large-scale study co-authored by Dr. James Wrobel, DPM, MS, Associate Professor of Medicine at Rosalind Franklin University of Medicine and Science.

5 Aug 2010

Harden Healthcare acquires Voyager HospiceCare, combined company to provide healthcare services in 13 states

Harden Healthcare announced today the purchase of Voyager HospiceCare. Headquartered in Austin, the combined company will provide healthcare services in 13 states and will employ approximately 32,000 full-time and part-time associates in nearly 200 locations.

5 Aug 2010

Alnylam second-quarter revenues increase to $26.6 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.

5 Aug 2010

Shire proposes acquisition of Movetis for fully diluted equity purchase price of EUR428 million

Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.

5 Aug 2010

Injecting PAP may reduce chronic pain: Research

A study published in the Aug. 4, 2010 issue of the Journal of Neuroscience introduces an enzyme that could pack a big punch in the battle against chronic pain. Its name is prostatic acid phosphatase or PAP for short. According to researchers at the University of North Carolina at Chapel Hill, PAP blocks pain in animal models by siphoning off a molecule called PIP2—a critical component of the chemical cascade behind chronic pain.

5 Aug 2010

Missouri voters reject health reform law's 'individual mandate' to buy insurance

"Missouri law now contains a direct challenge to the federal health care law passed earlier this year. Primary voters approved Proposition C by a wide margin Tuesday. ... The measure is intended to invalidate in Missouri a key element of the federal health care law passed by Congress and signed by President Barack Obama in March. That law requires individuals to purchase health insurance beginning in 2014."

5 Aug 2010

Pakistan floods prompt food shortages, devastate farmland

Pakistanis in the northwest part of the country face "life-threatening shortages" of food after flooding has killed 1,400 and "devastated the lives of more than three million people," Reuters reports. World Food Programme spokesman Amjad Jamal said, "People have lost their food stocks. The markets are not up and running. Shops have collapsed. People are definitely in the greatest need of food" (Ali, 8/4).

5 Aug 2010

Medical News

ARIAD reports $159.3 million second-quarter net income

Bionovo reports total revenue of $14,000 for second-quarter 2010

Genzyme, Isis announce results of two mipomersen phase 3 studies

Healthcare professionals to share therapeutic hypothermia knowledge at 'Cool It' program

Abiomed first-quarter fiscal 2011 revenue increases 11% to $22.0 million

Elusys awarded second contract to develop Anthim for treatment of anthrax infection

Penn. effort fades to override cuts to family planning; Ill. faces budget cuts to health care; Mich. focuses on high cost of chronic disease

Teleflex announces pricing of $350 million 3.875% convertible senior subordinated notes due 2017

Scientists analyze new technique to quickly identify particular asthma subtypes

TapImmune inks smallpox vaccine Research and Technology License Option Agreement with Mayo Clinic

Senate Democrats hang hopes for state Medicaid money on Maine Republican votes

West Michigan Business Review names DCC as 2010 Michigan Innovator

Certain proteins, genes play key role in regenerating lost body parts: Research

Amputation can be prevented when patients are treated by podiatric physicians: Study

Harden Healthcare acquires Voyager HospiceCare, combined company to provide healthcare services in 13 states

Alnylam second-quarter revenues increase to $26.6 million

Shire proposes acquisition of Movetis for fully diluted equity purchase price of EUR428 million

Injecting PAP may reduce chronic pain: Research

Missouri voters reject health reform law's 'individual mandate' to buy insurance

Pakistan floods prompt food shortages, devastate farmland

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News